Ellis-van Creveld syndrome (EVC syndrome) is an inherited disorder belonging to the group of dysplasias characterized by developmental abnormalities such as massive arterial hypoplasia, short limbs, and a range of stomatognathic anomalies. The disorder is associated with autosomal recessive transmission of genetic information and is usually accompanied by additional anomalies, including cardiac defects and other systemic changes. The syndrome is more common in certain ethnic groups, which is associated with a high rate of inbreeding among them. The key features of this condition are limb dystrophy and growth disturbance, which causes significant functional limitations and requires a comprehensive approach to diagnosis and treatment.
History of the disease and interesting historical facts
Ellis-van Creveld syndrome was first described in 1940 by American pediatricians Melvin Ellis and Aaron Van Creveld. In subsequent years, this disease became the subject of numerous studies, which allowed for a detailed study of its clinical manifestations and genetic mechanisms. An important point is that the syndrome is most often observed in the population belonging to the Amesha and other closed ethnic groups, which is due to limited genetic diversity. Historically, the syndrome was studied in the context of its impact on the quality of life and social adaptation of patients, which led to the development of specialized programs for the support and rehabilitation of patients.
Epidemiology
According to epidemiological data, the prevalence of Ellis-van Creveld syndrome is approximately 1 in 60,000 newborns, but in highly inbreeding populations such as the Amesha, this figure increases to 1 in 2,000 to 3,000. Experts note that in this population group, the incidence of this disease is significantly higher than in the general population, which is due to the hereditary nature and the peculiarities of reproductive practices. At the same time, high incidence rates in certain ethnic groups highlight the need for genetic counseling for families with a potential risk of transmitting the gene associated with this syndrome.
Genetic predisposition to this disease
The genetic basis of Ellis-van Creveld syndrome is associated with mutations in the EVC (Evangelical.) gene, which is located on chromosome 4. Some patients also have mutations in the neighboring EVC2 gene. Both of these genes are responsible for the normal development of tissues and organs, and their disruption leads to the formation of characteristic features of the syndrome. Genetic tests aimed at identifying mutations in these genes are becoming an important tool for diagnosis and determining the risks for future generations. Studies have shown that more than 95% cases are the result of autosomal recessive inheritance, which emphasizes the large role of inbreeding in the spread of this disease.
Risk factors for the development of this disease
Although Ellis-van Creveld syndrome is primarily hereditary, several factors have been identified that contribute to its occurrence. The main risk factors include:
- Inbreeding in closed populations.
- Presence of cases of the disease in the family history.
- Age of parents, especially fathers, at conception.
- A diet deficient in important vitamins and microelements.
- Environmental factors, including exposure to chemicals and pollutants.
Understanding these factors is important for developing prevention programs, especially in communities with a high risk of transmission of the syndrome.
Diagnosis of this disease
Diagnosis of Ellis-van Creveld syndrome is based on clinical examination and additional research methods. The main symptoms include:
- Limb deformities, including shortening and growth deficiency.
- Stomatognathic anomalies such as fusion of teeth and loss of dental enamel.
- Heart defects that can be detected by ECG and echocardiography.
- Legg anomalies and other dysplasias detected on radiography.
Laboratory tests may include genetic tests for mutations in the EVC and EVC2 genes, which confirm the diagnosis. Radiological examinations, such as ultrasound and MRI, allow us to evaluate structural changes in organs and systems. An important aspect is the differential diagnosis with other hereditary syndromes and developmental anomalies.
Treatment
Treatment of Ellis-van Creveld syndrome should be comprehensive and multidisciplinary. In the initial stages, surgical intervention may be required to correct orthopedic anomalies and improve limb function. Pharmacological therapy is aimed at managing associated conditions, such as heart defects or pulmonary disorders. Rehabilitation and support, including physical therapy and social adaptation, are an important area. In severe cases, a multidisciplinary approach involving cardiologists, orthopedists, and geneticists may be required.
List of medications used to treat this disease
There are a number of medications that can be used to help maintain the health of people with Ellis-van Creveld syndrome. These include:
- Cardiovascular support drugs (eg, beta blockers).
- Anti-inflammatory drugs (if necessary).
- Medicines for the correction of metabolic disorders.
- Vitamin and mineral complexes to support overall health.
The choice of specific medications depends on the individual characteristics of the patient and the presence of concomitant diseases.
Disease monitoring
Monitoring of patients with Ellis-van Creveld syndrome includes regular health checks and functional assessments. Monitoring steps should include:
- Regular examination by a pediatrician and other specialists (orthopedist, cardiologist).
- Genetic counseling to calculate risks for offspring.
- Radiological examinations to monitor the development of defects or abnormalities.
- Psychosocial support, including work with psychologists and social workers.
The prognosis for patients depends on the severity of the anomalies and the presence of comorbidities, while potential complications may be associated with cardiac and orthopedic problems.
Age-related features of the disease
Ellis-van Creveld syndrome can manifest itself differently depending on the patient's age. In newborns and infants, dystrophic changes and heart defects are most pronounced. In preschool age, stomatognathic anomalies can be noticeably manifested, which complicates the process of forming a full-fledged dentition. In adolescence, social interaction and the development of motor skills become relevant. In adult patients, the most significant problems are orthopedic deformities and somatic health, which requires constant attention.
Questions and Answers
- What are the main symptoms of Ellis-van Creveld syndrome? The main symptoms are shortened limbs, stomatognathic anomalies, heart defects and growth disorders.
- What is the heredity of this syndrome? The syndrome is transmitted in an autosomal recessive manner, which requires dual carriage of the mutant gene from both parents.
- What diagnostic methods are used to confirm the diagnosis? Includes clinical examination, genetic testing, radiological methods and laboratory tests.
- How is the syndrome treated? Treatment includes surgical, pharmacological and rehabilitative approaches aimed at improving the patient's quality of life.
- What are the risks and complications of this disease? The most common risks are related to cardiac and orthopedic abnormalities, which can affect overall life expectancy and quality of life.
Doctor Oleg Korzhikov emphasizes the importance of early diagnosis and constant monitoring of the patient's condition. Each patient needs an individual approach, including the development of a rehabilitation program and psychological support. Parents of patients with the syndrome should pay attention to the voice and language skills of children, which helps in social adaptation. Regular monitoring by specialists will ensure early correction of emerging problems and improve the quality of life of patients.
